Literature DB >> 3674766

S-phase rate as a predictor of early recurrences in carcinoma of the uterine cervix.

P Strang1, G Eklund, U Stendahl, B Frankendal.   

Abstract

Flow cytometric measurements of ploidy level and S-phase rate were performed in a prospective study of 165 patients with cervical squamous cell carcinoma. Patients were followed-up for 24 months after initial treatment. There was no significant difference in recurrence rate between patients with peri-diploid tumors (1.8c-2.2c) and aneuploid tumors. The S-phase rate (evaluable in 133 cases), which previously has been studied only occasionally in cervical carcinomas, was correlated with early relapses. Significantly more relapses were found in tumors with S-phase rates greater than or equal to 20% than among tumors with S-phase rates less than 20% (chi 2 = 9.54, p less than 0.01). A higher relapse rate among tumors with S-phase rates greater than or equal to 20% was found even after taking staging into consideration (Cochran-Mantel-Haenszel test, p less than 0.01). Thus, besides staging, evaluation of the S-phase rate yielded additional prognostic information.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3674766

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Factors influencing tumor cell kinetics in cervical cancer.

Authors:  T M Chen; Y H Chen; C C Wu; C A Chen; C F Chang; C Y Hsieh
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Comparison of proliferation rates assessed using "multiblock" and conventional tissue blocks of lung carcinoma.

Authors:  D C Brown; K C Gatter
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

3.  Monoclonal antibody JC1: new reagent for studying cell proliferation.

Authors:  M C Garrido; J L Cordell; M H Becker; G Key; J Gerdes; M Jones; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

4.  DNA cell-cycle analysis of cervical cancer by flow cytometry using simultaneous cytokeratin labelling for identification of tumour cells.

Authors:  R Kimmig; T Kapsner; H Spelsberg; M Untch; H Hepp
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

5.  Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate.

Authors:  B S Bolger; R P Symonds; P D Stanton; A B MacLean; R Burnett; P Kelly; T G Cooke
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

6.  Measurement of cell kinetics in cervical tumours using bromodeoxyuridine.

Authors:  B S Bolger; T G Cooke; R P Symonds; A B MacLean; P D Stanton
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.